524790 Stock Overview
Everest Organics Limited engages in the manufacture and sale of active pharmaceutical ingredients and its intermediaries in India.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Everest Organics Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹124.60 |
52 Week High | ₹161.70 |
52 Week Low | ₹97.02 |
Beta | 0.85 |
1 Month Change | 0.36% |
3 Month Change | -15.87% |
1 Year Change | 20.22% |
3 Year Change | -49.35% |
5 Year Change | -36.00% |
Change since IPO | 931.17% |
Recent News & Updates
Recent updates
Shareholder Returns
524790 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -2.7% | -2.8% | -1.5% |
1Y | 20.2% | 54.9% | 45.0% |
Return vs Industry: 524790 underperformed the Indian Pharmaceuticals industry which returned 54.9% over the past year.
Return vs Market: 524790 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
524790 volatility | |
---|---|
524790 Average Weekly Movement | 5.3% |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524790 has not had significant price volatility in the past 3 months.
Volatility Over Time: 524790's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 400 | Srikakarlapudi Sirisha | www.everestorganicsltd.com |
Everest Organics Limited engages in the manufacture and sale of active pharmaceutical ingredients and its intermediaries in India. It also manufactures bulk drugs. The company exports its products to Europe, the United States, the Far East and the Middle East, and Latin/Central/South American countries.
Everest Organics Limited Fundamentals Summary
524790 fundamental statistics | |
---|---|
Market cap | ₹996.80m |
Earnings (TTM) | ₹1.94m |
Revenue (TTM) | ₹1.96b |
512.8x
P/E Ratio0.5x
P/S RatioIs 524790 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524790 income statement (TTM) | |
---|---|
Revenue | ₹1.96b |
Cost of Revenue | ₹1.31b |
Gross Profit | ₹654.20m |
Other Expenses | ₹652.25m |
Earnings | ₹1.94m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.24 |
Gross Margin | 33.34% |
Net Profit Margin | 0.099% |
Debt/Equity Ratio | 111.7% |
How did 524790 perform over the long term?
See historical performance and comparison